• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧视神经萎缩 1 型()相关疾病-病例报告及文献复习。

Biallelic Optic Atrophy 1 () Related Disorder-Case Report and Literature Review.

机构信息

Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.

College of Osteopathic Medicine, Des Moines University, Des Moines, IA 50312, USA.

出版信息

Genes (Basel). 2022 Jun 2;13(6):1005. doi: 10.3390/genes13061005.

DOI:10.3390/genes13061005
PMID:35741767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9223020/
Abstract

Dominant optic atrophy (DOA), MIM # 605290, is the most common hereditary optic neuropathy inherited in an autosomal dominant pattern. Clinically, it presents a progressive decrease in vision, central visual field defects, and retinal ganglion cell loss. A biallelic mode of inheritance causes syndromic DOA or Behr phenotype, MIM # 605290. This case report details a family with Biallelic Optic Atrophy 1 (OPA1). The proband is a child with a severe phenotype and two variants in the OPA1 gene. He presented with congenital nystagmus, progressive vision loss, and optic atrophy, as well as progressive ataxia, and was found to have two likely pathogenic variants in his OPA1 gene: c.2287del (p.Ser763Valfs*15) maternally inherited and c.1311A>G (p.lIle437Met) paternally inherited. The first variant is predicted to be pathogenic and likely to cause DOA. In contrast, the second is considered asymptomatic by itself but has been reported in patients with DOA phenotype and is presumed to act as a phenotypic modifier. On follow-up, he developed profound vision impairment, intractable seizures, and metabolic strokes. A literature review of reported biallelic OPA1-related Behr syndrome was performed. Twenty-one cases have been previously reported. All share an early-onset, severe ocular phenotype and systemic features, which seem to be the hallmark of the disease.

摘要

显性视神经萎缩(DOA),MIM #605290,是最常见的常染色体显性遗传视神经病变。临床上表现为视力进行性下降、中心视野缺损和视网膜神经节细胞丢失。双等位基因突变导致综合征性 DOA 或 Behr 表型,MIM #605290。本病例报告详细介绍了一个具有双等位基因视神经萎缩 1 型(OPA1)的家族。先证者是一名儿童,表现为严重表型,OPA1 基因有两个变异。他患有先天性眼球震颤、进行性视力丧失和视神经萎缩,以及进行性共济失调,并在 OPA1 基因中发现了两个可能的致病变异:c.2287del(p.Ser763Valfs*15)母系遗传和 c.1311A>G(p.lIle437Met)父系遗传。第一个变异被预测为致病性的,很可能导致 DOA。相比之下,第二个变异本身被认为是无症状的,但已在具有 DOA 表型的患者中报道,被认为是表型修饰剂。随访时,他出现了严重的视力损害、难治性癫痫和代谢性中风。对报告的双等位基因 OPA1 相关 Behr 综合征进行了文献复习。以前已经报告了 21 例。所有病例均具有早发性、严重的眼部表型和全身特征,这似乎是该疾病的标志。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/5688a6514d5a/genes-13-01005-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/b70086240cc3/genes-13-01005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/6fd3a5f66cf0/genes-13-01005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/805642bec9dd/genes-13-01005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/5f57f90460db/genes-13-01005-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/60c67f923f47/genes-13-01005-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/444b514348c2/genes-13-01005-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/29375868984a/genes-13-01005-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/5688a6514d5a/genes-13-01005-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/b70086240cc3/genes-13-01005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/6fd3a5f66cf0/genes-13-01005-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/805642bec9dd/genes-13-01005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/5f57f90460db/genes-13-01005-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/60c67f923f47/genes-13-01005-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/444b514348c2/genes-13-01005-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/29375868984a/genes-13-01005-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/9223020/5688a6514d5a/genes-13-01005-g008.jpg

相似文献

1
Biallelic Optic Atrophy 1 () Related Disorder-Case Report and Literature Review.双侧视神经萎缩 1 型()相关疾病-病例报告及文献复习。
Genes (Basel). 2022 Jun 2;13(6):1005. doi: 10.3390/genes13061005.
2
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.与OPA1基因新的复合杂合突变相关的隐性视神经萎缩、感觉运动神经病和白内障。
Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4.
3
Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies.对疑似遗传性视神经病变患者的 OPA1 和 OPA3 突变进行基因筛查。
Ophthalmology. 2011 Mar;118(3):558-63. doi: 10.1016/j.ophtha.2010.07.029. Epub 2010 Oct 30.
4
Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.由深内含子 OPA1 突变和基因内修饰物引起的单纯型和综合征型视神经萎缩。
Brain. 2014 Aug;137(Pt 8):2164-77. doi: 10.1093/brain/awu165. Epub 2014 Jun 25.
5
The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.OPA1 突变导致的显性视神经萎缩的患病率和自然史。
Ophthalmology. 2010 Aug;117(8):1538-46, 1546.e1. doi: 10.1016/j.ophtha.2009.12.038. Epub 2010 Apr 24.
6
Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.对193个疑似遗传性视神经病变的中国家庭进行视神经萎缩1基因的突变检测。
Mol Vis. 2013;19:292-302. Epub 2013 Feb 6.
7
Autosomal dominant optic atrophy with gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort.日本队列中伴有基因突变的常染色体显性遗传性视神经萎缩,伴有听觉神经病和其他全身并发症。
Mol Vis. 2019 Oct 5;25:559-573. eCollection 2019.
8
First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report.首次发现显性视神经萎缩中 OPA1 基因的亚微观反转 - 病例报告。
BMC Med Genet. 2020 Nov 26;21(1):236. doi: 10.1186/s12881-020-01166-z.
9
Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations.早发型严重神经肌肉表型与 OPA1 突变的复合杂合性相关。
Mol Genet Metab. 2011 Aug;103(4):383-7. doi: 10.1016/j.ymgme.2011.04.018. Epub 2011 May 7.
10
OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.OPA1 基因治疗可预防显性视神经萎缩模型小鼠的视网膜神经节细胞丢失。
Sci Rep. 2018 Feb 6;8(1):2468. doi: 10.1038/s41598-018-20838-8.

引用本文的文献

1
Novel in vivo models of autosomal optic atrophy reveal conserved pathological changes in neuronal mitochondrial structure and function.常染色体性视神经萎缩的新型体内模型揭示了神经元线粒体结构和功能中保守的病理变化。
FASEB J. 2025 Apr 15;39(7):e70497. doi: 10.1096/fj.202403271R.
2
Severe mitochondrial encephalomyopathy caused by variants in gene.由基因变异引起的严重线粒体脑肌病。
Front Genet. 2024 Aug 20;15:1437959. doi: 10.3389/fgene.2024.1437959. eCollection 2024.
3
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?遗传性共济失调:从基础到临床,我们处于什么位置?

本文引用的文献

1
OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.OPA1:在更新的集中式变异数据库中注册了 516 个独特变体和 831 名患者。
Orphanet J Rare Dis. 2019 Sep 10;14(1):214. doi: 10.1186/s13023-019-1187-1.
2
Metabolic stroke in a patient with bi-allelic OPA1 mutations.携 OPA1 双等位基因突变患者的代谢性卒中。
Metab Brain Dis. 2019 Aug;34(4):1043-1048. doi: 10.1007/s11011-019-00415-2. Epub 2019 Apr 10.
3
Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models.
Cells. 2024 Feb 9;13(4):319. doi: 10.3390/cells13040319.
4
Recurrent super-refractory status epilepticus and stroke like episode in a patient with Behr syndrome secondary to biallelic variants in OPA1 gene.一名因OPA1基因双等位基因变异继发贝赫综合征的患者出现反复超难治性癫痫持续状态和类中风发作。
Epilepsy Behav Rep. 2024 Feb 6;25:100652. doi: 10.1016/j.ebr.2024.100652. eCollection 2024.
5
Establishing induced pluripotent stem cell lines from two dominant optic atrophy patients with distinct mutations and clinical pathologies.从两名具有不同突变和临床病理特征的显性遗传性视神经萎缩患者中建立诱导多能干细胞系。
Front Genet. 2023 Sep 4;14:1251216. doi: 10.3389/fgene.2023.1251216. eCollection 2023.
6
Combined MITOchondrial-NUCLEAR (MITO-NUCLEAR) Analysis for Mitochondrial Diseases Diagnosis: Validation and Implementation of a One-Step NGS Method.联合线粒体-核(MITO-NUCLEAR)分析在诊断线粒体疾病中的应用:一步式 NGS 方法的验证与实施。
Genes (Basel). 2023 May 15;14(5):1087. doi: 10.3390/genes14051087.
通过对人、鼠和酵母细胞模型的综合分析来破译 OPA1 突变的致病性。
Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3496-3514. doi: 10.1016/j.bbadis.2018.08.004. Epub 2018 Aug 4.
4
Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations.不仅是显性,不仅是视神经萎缩:扩展与OPA1突变相关的临床谱。
Orphanet J Rare Dis. 2017 May 12;12(1):89. doi: 10.1186/s13023-017-0641-1.
5
Leigh-like neuroimaging features associated with new biallelic mutations in OPA1.与OPA1基因新的双等位基因突变相关的 Leigh 样神经影像学特征。
Eur J Paediatr Neurol. 2017 Jul;21(4):671-677. doi: 10.1016/j.ejpn.2017.04.004. Epub 2017 Apr 15.
6
Genetic and Clinical Analyses of DOA and LHON in 304 Chinese Patients with Suspected Childhood-Onset Hereditary Optic Neuropathy.304例疑似儿童期起病遗传性视神经病变的中国患者中DOA和LHON的遗传学及临床分析
PLoS One. 2017 Jan 12;12(1):e0170090. doi: 10.1371/journal.pone.0170090. eCollection 2017.
7
Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations.OPA1 突变所致视神经萎缩中的线粒体自噬失调与线粒体组织紊乱
Neurology. 2017 Jan 10;88(2):131-142. doi: 10.1212/WNL.0000000000003491. Epub 2016 Dec 14.
8
Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).生成用于复杂视神经萎缩综合征(贝赫综合征)疾病建模的视神经萎缩1型患者来源的诱导多能干细胞(iPS-OPA1-BEHR)。
Stem Cell Res. 2016 Sep;17(2):426-429. doi: 10.1016/j.scr.2016.09.012. Epub 2016 Sep 17.
9
Recessive optic atrophy, sensorimotor neuropathy and cataract associated with novel compound heterozygous mutations in OPA1.与OPA1基因新的复合杂合突变相关的隐性视神经萎缩、感觉运动神经病和白内障。
Mol Med Rep. 2016 Jul;14(1):33-40. doi: 10.3892/mmr.2016.5209. Epub 2016 May 4.
10
A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function.在OPA1相关显性遗传性视神经萎缩小鼠模型中进行的关于苯醌艾地苯醌的随机、安慰剂对照试验显示,其对视网膜神经节细胞树突病变和视觉功能的治疗效果有限。
Neuroscience. 2016 Apr 5;319:92-106. doi: 10.1016/j.neuroscience.2016.01.042. Epub 2016 Jan 25.